Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid

Background. Liver transplant (LT) recipients with autoimmune liver disease (primary sclerosing cholangitis, primary biliary cholangitis, autoimmune hepatitis) are at increased risk of developing acute cellular rejection (ACR), and in many cases graft failure due to recurrent disease. We describe our...

Full description

Bibliographic Details
Main Authors: Sanjaya K. Satapathy, MBBS, MD, DM, Ollie D. Jones, MD, Jason M. Vanatta, MD, Faisal Kamal, MD, Satish K. Kedia, PhD, Yu Jiang, PhD, Satheesh P. Nair, MD, FAASLD, James D. Eason, MD
Format: Article
Language:English
Published: Wolters Kluwer 2017-07-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000693

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000693

Similar Items